Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|17 Nov 2016||Submitted||Original manuscript|
|3 Mar 2017||Reviewed||Reviewer Report - Samantha Oakes|
|23 Apr 2017||Reviewed||Reviewer Report - Sushanta Banerjee|
|25 Jul 2017||Author responded||Author comments - Federica Brugnoli|
|Resubmission - Version 2|
|25 Jul 2017||Submitted||Manuscript version 2|
|25 Jul 2017||Reviewed||Reviewer Report - Sushanta Banerjee|
|11 Aug 2017||Reviewed||Reviewer Report - Samantha Oakes|
|21 Aug 2017||Author responded||Author comments - Federica Brugnoli|
|Resubmission - Version 3|
|21 Aug 2017||Submitted||Manuscript version 3|
|22 Aug 2017||Editorially accepted|
|4 Sep 2017||Article published||10.1186/s12885-017-3592-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.